Overview

Properties

Applications

Our Abpromise guarantee covers the use of ab56702 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB
IHC-P
  • Application notesWB: Use at a concentration of 1-5 µg/ml.
    IHC-P: Use at a concentration of 3 µg/ml.


    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionTranscriptional regulator which can act both as a coactivator and a corepressor and is the critical downstream regulatory target in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein MST1/MST2, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Plays a key role to control cell proliferation in response to cell contact. Phosphorylation of YAP1 by LATS1/2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. The presence of TEAD transcription factors are required for it to stimulate gene expression, cell growth, anchorage-independent growth, and epithelial mesenchymal transition (EMT) induction. Isoform 2 and isoform 3 can activate the C-terminal fragment (CTF) of ERBB4 (isoform 3).
    • Tissue specificityIncreased expression seen in some liver and prostate cancers. Isoforms lacking the transactivation domain found in striatal neurons of patients with Huntington disease (at protein level).
    • Sequence similaritiesBelongs to the YORKIE family.
      Contains 2 WW domains.
    • Post-translational
      modifications
      Phosphorylated by LATS1 and LATS2; leading to cytoplasmic translocation and inactivation. Phosphorylated by ABL1; leading to YAP1 stabilization, enhanced interaction with TP73 and recruitment onto proapoptotic genes; in response to DNA damage.
    • Cellular localizationCytoplasm. Nucleus. Both phosphorylation and cell density can regulate its subcellular localization. Phosphorylation sequesters it in the cytoplasm by inhibiting its translocation into the nucleus. At low density, predominantly nuclear and is translocated to the cytoplasm at high density.
    • Information by UniProt
    • Database links
    • Alternative names
      • 65 kDa Yes associated protein antibody
      • 65 kDa Yes-associated protein antibody
      • COB1 antibody
      • YAp 1 antibody
      • YAP 65 antibody
      • YAP antibody
      • YAP1 antibody
      • YAP1_HUMAN antibody
      • YAP2 antibody
      • YAP65 antibody
      • yes -associated protein delta antibody
      • Yes associated protein 1 65kDa antibody
      • Yes associated protein 1 antibody
      • Yes associated protein 2 antibody
      • yes associated protein beta antibody
      • YKI antibody
      • Yorkie homolog antibody
      see all

    Anti-YAP1 antibody images

    • YAP1 antibody (ab56702) used in immunohistochemistry at 3ug/ml on formalin fixed and paraffin embedded human placenta.


    • Predicted band size : 49 kDa
      YAP1 antibody (ab56702) at 1ug/lane + HeLa cell lysate at 25ug/lane.

    References for Anti-YAP1 antibody (ab56702)

    ab56702 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab56702.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"